Updated Jul 16, 2026
Klotman Mary E. has filed 1 SEC Form 4 filing across 1 company in the last 90 days.
Mary E. Klotman is indicated by the most recent SEC filing (as of 2026-05-21) to serve as a director of Amgen Inc. The available SEC context confirms her role as a director but provides no additional biographical details.
| Role | Director |
|---|---|
| Notability | 65/100 |
| Date | Ticker | Company | Code | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 2026-05-21 | AMGN | AMGEN INC | A — Grant or award | 665 | $0.00 |
Mary E. Klotman is indicated by the most recent SEC filing (as of 2026-05-21) to serve as a director of Amgen Inc. The available SEC context confirms her role as a director but provides no additional biographical details.…
1 primary Form 4 filings in the last 90 days, covering 1 company.
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Open the live Klotman Mary E. profile on InsiderAlpha for real-time alerts, AI-scored trade ideas, and full transaction history.